These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2672252)

  • 21. [In vitro effect of various antibiotics: beta lactams, aminoglycosides and fluoroquinolones alone and in combination against P. aeruginosa isolated from patients with mucoviscidosis].
    Croize J; Gout JP; Robert J; Le Noc P
    Pathol Biol (Paris); 1989 Jun; 37(5 Pt 2):573-7. PubMed ID: 2508041
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ciprofloxacin monotherapy for acute pulmonary exacerbations of cystic fibrosis.
    Goldfarb J; Stern RC; Reed MD; Yamashita TS; Myers CM; Blumer JL
    Am J Med; 1987 Apr; 82(4A):174-9. PubMed ID: 3555032
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Management of pulmonary disease in patients with cystic fibrosis.
    Ramsey BW
    N Engl J Med; 1996 Jul; 335(3):179-88. PubMed ID: 8657217
    [No Abstract]   [Full Text] [Related]  

  • 24. Antimicrobial therapy for pulmonary pathogenic colonisation and infection by Pseudomonas aeruginosa in cystic fibrosis patients.
    Cantón R; Cobos N; de Gracia J; Baquero F; Honorato J; Gartner S; Alvarez A; Salcedo A; Oliver A; García-Quetglas E;
    Clin Microbiol Infect; 2005 Sep; 11(9):690-703. PubMed ID: 16104983
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Duration of intravenous antibiotic therapy in people with cystic fibrosis.
    Plummer A; Wildman M
    Cochrane Database Syst Rev; 2011 Jan; (1):CD006682. PubMed ID: 21249681
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Duration of intravenous antibiotic therapy in people with cystic fibrosis.
    Fernandes B; Plummer A; Wildman M
    Cochrane Database Syst Rev; 2008 Apr; (2):CD006682. PubMed ID: 18425963
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Duration of intravenous antibiotic therapy in people with cystic fibrosis.
    Plummer A; Wildman M
    Cochrane Database Syst Rev; 2013 May; (5):CD006682. PubMed ID: 23728662
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro susceptibility of Pseudomonas aeruginosa from bacteremic and fibrocystic patients to four quinolones and five other antipseudomonal antibiotics.
    Lester A; Andreasen JJ
    Scand J Infect Dis; 1988; 20(5):525-9. PubMed ID: 3146807
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of aztreonam in pulmonary exacerbations of cystic fibrosis.
    Bosso JA; Black PG; Matsen JM
    Pediatr Infect Dis J; 1987 Apr; 6(4):393-7. PubMed ID: 3588112
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of oral fluoroquinolones versus conventional intravenous antipseudomonal chemotherapy in treatment of cystic fibrosis.
    Jensen T; Pedersen SS; Høiby N; Koch C
    Eur J Clin Microbiol; 1987 Dec; 6(6):618-22. PubMed ID: 3326741
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tobramycin therapy of pulmonary infections in patients with cystic fibrosis.
    Hawley HB; Lewis RM; Swartz DR; Gump DW
    Curr Ther Res Clin Exp; 1974 May; 16(5):414-23. PubMed ID: 4209057
    [No Abstract]   [Full Text] [Related]  

  • 32. The quinolones and renal infection.
    Ronald A
    Drugs; 1999; 58 Suppl 2():96-8. PubMed ID: 10553715
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Antibiotic therapy and effects of respiratory physiotherapy techniques in cystic fibrosis patients treated for acute lung exacerbations: an experimental study].
    da Silva Santos CI; Gonçalves de Oliveira Ribeiro MA; Moreno Morcillo A; Fernando Ribeiro A; Dirceu Ribeiro J
    Arch Bronconeumol; 2010 Jun; 46(6):310-6. PubMed ID: 20417019
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative pharmacokinetics of ciprofloxacin and ofloxacin in cystic fibrosis patients.
    Pedersen SS; Jensen T; Hvidberg EF
    J Antimicrob Chemother; 1987 Oct; 20(4):575-83. PubMed ID: 3479419
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ciprofloxacin versus tobramycin plus azlocillin in pulmonary exacerbations in adult patients with cystic fibrosis.
    Bosso JA; Black PG; Matsen JM
    Am J Med; 1987 Apr; 82(4A):180-4. PubMed ID: 3555033
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The fluoroquinolones.
    Walker RC
    Mayo Clin Proc; 1999 Oct; 74(10):1030-7. PubMed ID: 10918871
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Comparative efficacy and safety of ciprofloxacin, ofloxacin, and pefloxacin in treatment of respiratory infections in children with cystic fibrosis].
    Postnikov SS
    Antibiot Khimioter; 2001; 46(3):16-20. PubMed ID: 11548276
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Investigation of plasmid-mediated quinolone resistance in Pseudomonas aeruginosa strains isolated from cystic fibrosis patients].
    Coban AY; Tanrıverdi Çaycı Y; Yıldırım T; Erturan Z; Durupınar B; Bozdoğan B
    Mikrobiyol Bul; 2011 Oct; 45(4):602-8. PubMed ID: 22090290
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Susceptibility of bacterial isolates from AIDS patients to six fluoroquinolones.
    Lewin CS; Naden M; Watt B; Amyes SG
    J Pharm Pharmacol; 1990 Nov; 42(11):808-9. PubMed ID: 1982310
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rufloxacin (MF-934): in vitro and in vivo antibacterial activity.
    Ravizzola G; Pinsi G; Pirali F; Colombrita D; Foresti I; Peroni L; Turano A
    Drugs Exp Clin Res; 1989; 15(1):11-5. PubMed ID: 2743869
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.